Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Lintzeris

Showing results (81-90 of 196) with videos related to

Pageof 20
Sort By:
Pain Medicine (Malden, Mass.)|October 9, 2019
Development of a Brief Patient-Administered Screening Tool for Prescription Opioid Dependence for Primary Care SettingsSuzanne Nielsen, Louisa Picco, Gabrielle Campbell, et al.
Drug and Alcohol Review|July 17, 2015
Injecting buprenorphine-naloxone film: Findings from an explorative qualitative studyNancy White, Ian Flaherty, Peter Higgs, et al.
Drug and Alcohol Review|April 19, 2013
Correlates of pain in an in-treatment sample of opioid-dependent peopleSuzanne Nielsen, Briony Larance, Nicholas Lintzeris, et al.
International Psychogeriatrics|September 24, 2014
Screening for alcohol and substance use for older people in geriatric hospital and community health settingsBrian Draper, Nicole Ridley, Carly Johnco, et al.
The Lancet. Psychiatry|January 17, 2018
The effect of a potentially tamper-resistant oxycodone formulation on opioid use and harm: main findings of the National Opioid Medications Abuse Deterrence (NOMAD) studyBriony Larance, Timothy Dobbins, Amy Peacock, et al.
Drug and Alcohol Dependence|January 28, 2014
The diversion and injection of a buprenorphine-naloxone soluble film formulationBriony Larance, Nicholas Lintzeris, Robert Ali, et al.
BMJ Open|May 19, 2021
Safety and tolerability of oral lisdexamfetamine in adults with methamphetamine dependence: a phase-2 dose-escalation studyNadine Ezard, Brendan Clifford, Adrian Dunlop, et al.
Drug and Alcohol Review|May 13, 2020
Assessing the validity of the Australian Treatment Outcomes Profile for telephone administration in drug health treatment populationsRachel M Deacon, Kristie Mammen, Jennifer Holmes, et al.
The International Journal on Drug Policy|April 18, 2024
The dynamics of more-than-human care in depot buprenorphine treatment: A new materialist analysis of Australian patients' experiencesAnthony Barnett, Kiran Pienaar, Dan I Lubman, et al.
Australian Journal of Primary Health|November 19, 2025
Understanding issues of driving safety and transport utilisation among clients receiving opioid agonist treatment: a cross-sectional survey in New South Wales, AustraliaDaniel T Winter, Lauren A Monds, Nicholas Lintzeris, et al.
Pageof 20

Showing results (81-90 of 196) with videos related to

Sort By:
Pageof 20
Pain Medicine (Malden, Mass.)|October 9, 2019
Development of a Brief Patient-Administered Screening Tool for Prescription Opioid Dependence for Primary Care SettingsSuzanne Nielsen, Louisa Picco, Gabrielle Campbell, et al.
Drug and Alcohol Review|July 17, 2015
Injecting buprenorphine-naloxone film: Findings from an explorative qualitative studyNancy White, Ian Flaherty, Peter Higgs, et al.
Drug and Alcohol Review|April 19, 2013
Correlates of pain in an in-treatment sample of opioid-dependent peopleSuzanne Nielsen, Briony Larance, Nicholas Lintzeris, et al.
International Psychogeriatrics|September 24, 2014
Screening for alcohol and substance use for older people in geriatric hospital and community health settingsBrian Draper, Nicole Ridley, Carly Johnco, et al.
The Lancet. Psychiatry|January 17, 2018
The effect of a potentially tamper-resistant oxycodone formulation on opioid use and harm: main findings of the National Opioid Medications Abuse Deterrence (NOMAD) studyBriony Larance, Timothy Dobbins, Amy Peacock, et al.
Drug and Alcohol Dependence|January 28, 2014
The diversion and injection of a buprenorphine-naloxone soluble film formulationBriony Larance, Nicholas Lintzeris, Robert Ali, et al.
BMJ Open|May 19, 2021
Safety and tolerability of oral lisdexamfetamine in adults with methamphetamine dependence: a phase-2 dose-escalation studyNadine Ezard, Brendan Clifford, Adrian Dunlop, et al.
Drug and Alcohol Review|May 13, 2020
Assessing the validity of the Australian Treatment Outcomes Profile for telephone administration in drug health treatment populationsRachel M Deacon, Kristie Mammen, Jennifer Holmes, et al.
The International Journal on Drug Policy|April 18, 2024
The dynamics of more-than-human care in depot buprenorphine treatment: A new materialist analysis of Australian patients' experiencesAnthony Barnett, Kiran Pienaar, Dan I Lubman, et al.
Australian Journal of Primary Health|November 19, 2025
Understanding issues of driving safety and transport utilisation among clients receiving opioid agonist treatment: a cross-sectional survey in New South Wales, AustraliaDaniel T Winter, Lauren A Monds, Nicholas Lintzeris, et al.
Pageof 20